Home Technology Ex-Google DeepMind Researcher Warns AI Could ‘Kill All Humans’
Technology

Ex-Google DeepMind Researcher Warns AI Could ‘Kill All Humans’

Share
Ex-Google DeepMind Researcher Warns AI Could ‘Kill All Humans’
Share

A former Google DeepMind researcher has joined a growing group of AI experts warning that increasingly advanced artificial intelligence could pose an existential threat to humanity.

Bilal Chughtai, who worked on artificial general intelligence (AGI) safety and alignment research at DeepMind before leaving the company in July, said he believes AI has the potential to “kill us all” and warned that time to prevent such an outcome could be running out.

His comments follow similar warnings from researchers at Anthropic, including Evan Hubinger, who has estimated a greater than 10% chance that AI could cause human extinction within the next decade. The warnings have intensified debate over whether the development of increasingly powerful AI systems is moving too quickly.

Chughtai said safely developing advanced AI remains possible but would require greater coordination among technology companies and a slower pace of development, allowing emerging risks to be addressed before they result in serious harm.

See also  UK Spends Nearly $40 Million on SpaceX Military Satellite Services
Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

China Blocks SoftBank’s $5.4 Billion Acquisition of ABB’s Robotics Division

China has blocked Japanese investment giant SoftBank’s proposed $5.4 billion acquisition of...

Sony Profits Surge as Spider-Man Boosts Earnings, While Nintendo Reports Decline

Sony has reported a significant increase in quarterly profits, supported by strong...

Microsoft Drops Plans to Expand Texas AI Data Centre Deal with Nscale

Microsoft has decided not to expand its existing artificial intelligence infrastructure agreement...

England Launches Major NHS Blood Test Trial to Detect Cancer Earlier

A new government-funded trial involving more than 20,000 NHS patients will investigate...